Cite
HARVARD Citation
Jeong, J. et al. (n.d.). 15PA pilot study of single pegfilgrastim compared with intermittent every other days of 5 shot-filgrastim in breast cancer patients receiving adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy (G-CSF 105 trial: NCT02685111). Annals of oncology. p. . [Online].